SEARCH

SEARCH BY CITATION

References

  • 1
    Kijas JMH, Bauer TR Jr, Gafvert S, et al. A missense mutation in the β2-integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics 1999;61:101107.
  • 2
    Kehrli ME Jr, Ackermann MR, Shuster DE, et al. Animal model of human disease: Bovine leukocyte adhesion deficiency: β2 integrin deficiency in young Holstein cattle. Am J Pathol 1992; 140:14891492.
  • 3
    Anderson DC, Springer TA. Leukocyte adhesion deficiency: An inherited defect of Mac-1, LFA-1, and p159,95 glycoproteins. Annu Rev Med 1987;35:175221.
  • 4
    Kuijpers TW, van Lier RAW, Hamann D, et al. Leukocyte adhesion deficiency type 1 (LAD-l)/variant. A novel immunodeficiency syndrome characterized by dysfunctional β2 integrins. J Clin Invest 1997;100:17251734.
  • 5
    Etzioni A, Frydman M, Pollack S, et al. Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 1992;327:17891792.
  • 6
    Delisser HM, Christofidou-Solomidou M, Sun J, et al. Loss of endothelial surface expression of E-selectin in a patient with recurrent infections. Blood 1999;94:884894.
  • 7
    Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993;91: 379387.
  • 8
    Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:10331036.
  • 9
    Walcheck B, White M, Kurk S, et al. Characterization of the bovine peripheral lymph node homing receptor: A lectin cell adhesion molecule (LECAM). Eur J Immunol 1992;22:469476.
  • 10
    Lasky LA. Selectins: Interpreters of cell specific carbohydrate information during inflammation. Science 1992;258:964969.
  • 11
    Tedder TF, Steeber DA, Chen A, Engel P. The selectins: Vascular adhesion molecules. FASEB J 1995;9:866873.
  • 12
    Li X, Steeber DA, Tang MLK, et al. Regulation of L-selectin-mediated rolling through receptor dimerization. J Exp Med 1998;188: 13851390.
  • 13
    Vestweber D, Blanks JE. Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999;79:181213.
  • 14
    Burton JL, Kehrli ME jr. Regulation of neutrophil adhesion molecules and shedding of Staphylococcus aureus in milk of cortisoland dexamethasone-treated cows. Am J Vet Res 1995;56:9971006.
  • 15
    Crockett-Torabi E, Fantone JC. L-selectin stimulation of canine neutrophil initiates calcium signal secondary to tyrosine kinase activation. Am J Physiol 1997;272(3 Pt 2):H1302H1308.
  • 16
    Kashima T, Hasegawa A, Iwata H, Inoue T. Expression of recombinant bovine L-selectin in Escherichia coli and insect cells. J Vet Med Sci 1999;61:251254.
  • 17
    Kubo H, Doyle NA, Graham L, et al. L- and P-selectin and CD11/CD18 in intracapillary neutrophil sequestration in rabbit lungs. Am J Respir Crit Care Med 1997;159:267274.
  • 18
    Ma X-L, Weyrich AS, Lefer DJ, et al. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 1993;88:649658.
  • 19
    Monfardini E, Burvenich C, Massart-Leen AM, et al. Effect of antibiotic induced bacterial clearance in the udder on L-selectin shedding of blood neutrophils in cows with Escherichia coli mastitis. Vet Immunol Immunopathol 1999;67:373384.
  • 20
    Mulligan MS, Miyasaka M, Tamatani T, et al. Requirements for L-selectin in neutrophil-mediated lung injury in rats. J Immunol 1994; 152:832840.
  • 21
    Sakurai H, Schmalstieg FC, Traber LD, et al. Role of L-selectin in physiological manifestations after burn and smoke inhalation injury in sheep. J Appl Physiol 1999;86:11511159.
  • 22
    Shailubhai K, Streeter PR, Smith CE, Jacob GS. Sulfation and sialylation requirements for a glycoform of CD34, a major endothelial ligand for L-selectin in porcine peripheral lymph nodes. Glycobiology 1997;7:305314.
  • 23
    Tedder TF, Steeber DA, Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 1995;181:22592264.
  • 24
    Tsurushita N, Fu H, Berg EL. PCR cloning of the cDNA encoding baboon L-selectin. Gene 1996;28:219220.
  • 25
    Bosworth BT, Harp JA. Evidence for conservation of peripheral lymphocyte homing receptor between the bovine, murine and human species. Vet Immunol Immunopathol 1992;33:7988.
  • 26
    Jutila MA, Kurk S. Analysis of bovine gamma delta T cell interactions with E-, P-, and L-selectin. Characterization of lymphocyte on lymphocyte rolling and effects of O-glycoprotease. J Immunol 1996;156:289296.
  • 27
    Leid JG, Speer CA, Jutila MA. Comparative ultrastructure and expression of L-selectin on bovine alpha beta and gamma delta T cells. J Leukoc Biol 1998;64:104107.
  • 28
    Walcheck B, Jutila MA. Bovine gamma delta T cells express high levels of functional peripheral lymph node homing receptor (L-selectin). Int Immunol 1994;6:8191.
  • 29
    Wilson E, Walcheck B, Davis WC, Jutila MA. Preferential localization of bovine gamma delta T cell subsets defined by anti-T cell receptor for antigen antibodies. Immunol Lett 1998;64:3944.
  • 30
    Steeber DA, Tang ML, Green NE, et al. Leukocyte entry into sites of inflammation requires overlapping interactions between the L-selectin and ICAM-1 pathways. J Immunol 1999;163:21762186.
  • 31
    Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992;119:229238.
  • 32
    Von Andrian UH, Chambers JD, McEvory LM, et al. Two-step model of leukocyte endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte β2 integrins in vivo. Proc Natl Acad Sci USA 1991;88:75387542.
  • 33
    Geng J-G, Bevilacqua MP, Moore KL, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990;343:757760.
  • 34
    McEver RP, Beckstead JH, Moore KL, et al. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989;84:9299.
  • 35
    Fujimoto T, McEver RP. The cytoplasmic domain of P-selectin is phosphorylated on serine and threonine residues. Blood 1993;82: 17581766.
  • 36
    Burns AR, Bowden RA, Abe Y, et al. P-selectin mediates neutrophil adhesion to endothelial cell borders. J Leukoc Biol 1999;65: 299306.
  • 37
    Setiadi H, Sedgewick G, Erlandsen SL, McEver RP. Interactions of the cytoplasmic domain of P-selectin with clathrin-coated pits enhance leukocyte adhesion under flow. J Cell Biol 1998;142:859871.
  • 38
    Green SA, Setiadi H, McEver RP, Kelly RB. The cytoplasmic domain of P-selectin contains a sorting determinant that mediates rapid degradation in lysosomes. J Cell Biol 1994;124:435448.
  • 39
    Buerke M, Weyrich AS, Zheng Z, et al. Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 1994;93:11401148.
  • 40
    Dore M, Simon SI, Hughes BJ, et al. P-selectin and CD18-mediated recruitment of canine neutrophils under conditions of shear stress. Vet Pathol 1995;32:258268.
  • 41
    Miura T, Nelson DP, Schermerhorn ML, et al. Blockade of selectin-mediated leukocyte adhesion improves postischemic function in lamb hearts. Ann Thorac Surg 1996;62:12951300.
  • 42
    Strubel NA, Nguyen M, Kansas GS, et al. Isolation and characterization of a bovine cDNA encoding a functional homolog of human P-selectin. Biochem Biophys Res Commun 1993;192:338344.
  • 43
    Wang Y, Paape MJ, Leino L, et al. Functional and phenotypic characterization of monoclonal antibodies to bovine L-selectin. Am J Vet Res 1997;58:13921401.
  • 44
    Weyrich AS, Ma XY, Lefer DJ, et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993;91:26202629.
  • 45
    Chenier S, Dore M. P-selectin expression in canine cutaneous inflammatory diseases and mast cell tumors. Vet Pathol 1998;35:8593.
  • 46
    Katayama M, Handa M, Araki Y, et al. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome. Br J Haematol 1993;84:702710.
  • 47
    Davi G, Romano M, Mezzetti A, et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998;97: 953957.
  • 48
    Ertenli I, Kiraz S, Arici M, et al. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol 1998;25:10541058.
  • 49
    Ferroni P, Basili S, Martini F, et al. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med 2000;48:2127.
  • 50
    Xu DY, Zhao SP, Peng WP. Elevated plasma levels of soluble P-selectin in patients with acute myocardial infarction and unstable angina. An inverse link to lipoprotein(a). Int J Cardiol 1998;64:253258.
  • 51
    Huber TS, Gaines GC, Welborn MB III, et al. Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. Shock 2000;13:425434.
  • 52
    Phillips ML, Nudelman E, Gaeta FCA, et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 1990;250:11301132.
  • 53
    Read MA, Whitely MZ, Williams AJ, Collins T. NF-kappa B and I kappa B alpha: An inducible regulatory system in endothelial activation. J Exp Med 1994;179:503512.
  • 54
    Subramaniam M, Koedam JA, Wagner DD. Divergent fates of P- and E-selectins after their expression on the plasma membrane. Mol Biol Cell 1993;4:791801.
  • 55
    Berman AE, Kozlova NI. Integrins: Structure and functions. Membr Cell Biol 2000;13:207244.
  • 56
    Shimizu Y, Newman Y, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992;13:106112.
  • 57
    Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990;4:28682880.
  • 58
    Guan J-L, Hynes RO. Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor α4β1. Cell 1990;60:5361.
  • 59
    Hynes RO. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 1992;69:1125.
  • 60
    Takamatsu Y, Simmons PJ, Levesque JP. Dual control by divalent cations and mitogenic cytokines of α4β1 and α5β1 integrin avidity expressed by human hemopoietic cells. Cell Adhes Commun 1998; 5:349366.
  • 61
    Herard AL, Pierrot D, Hinnrasky J, et al. Fibronectin and its α5β1-integrin receptor are involved in the wound-repair process of airway epithelium. Am J Physiol 1996;271(5 Pt 1):L726L733.
  • 62
    Watarai M, Funato S, Sasakawa C. Interaction of Ipa proteins of Shigella flexneri with α5β1 integrin promotes entry of the bacteria into mammalian cells. J Exp Med 1996;183:991999.
  • 63
    Bilsland CA, Springer TA. Cloning and expression of the chicken CD18 cDNA. J Leukoc Biol 1994;55:501506.
  • 64
    Shuster DE, Bosworth BT, Kehrli ME jr. Sequence of the bovine CD18-encoding cDNA: Comparison with the human and murine glycoproteins. Gene 1992;114:267271.
  • 65
    Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990;75:10371050.
  • 66
    Danilenko DM, Rossitto PV, Van der Vieren M, et al. A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte subpopulation in peripheral blood. J Immunol 1995;155:3544.
  • 67
    el Gabalawy H, Canvin J, Ma GM, et al. Synovial distribution of αd/CD 18, a novel leukointegrin. Comparison with other integrins and their ligands. Arthritis Rheum 1996;39:19131921.
  • 68
    Van der Vieren M, LE Trong M, Wood CL, et al. A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3. Immunity 1995;3:683690.
  • 69
    Lee EK, Kehrli ME Jr, Dietz AB, et al. Cloning and sequencing of cDNA encoding bovine intercellular adhesion molecule 3 (ICAM-3). Gene 1996;174:311313.
  • 70
    Gilbert RO, Rebhun WC, Kim CA, et al. Clinical manifestations of leukocyte adhesion deficiency in cattle: 14 cases (1977–1991). J Am Vet Med Assoc 1993;202:445449.
  • 71
    Shuster DE, Kehrli ME Jr, Ackermann MR, Gilbert RO. Identification and prevalence of a genetic defect that causes leukocyte adhesion deficiency in Holstein cattle. Proc Natl Acad Sci USA 1992; 89:92259229.
  • 72
    Ackermann MR, Brogden KA, Florance AF, Kehrli ME jr. Induction of CD18-mediated passage of neutrophils by Pasteurella haemolytica in pulmonary bronchi and bronchioles. Infect Immun 1999; 67:659663.
  • 73
    Ackermann MR, Kehrli ME Jr, Brogden KA. Passage of CD18-and CD18+ bovine neutrophils into pulmonary alveoli during acute pneumonia. Vet Pathol 1996;33:639646.
  • 74
    Burns JA, Issekutz TB, Yagita H, Issekutz AC. The β2, α4, α5 integrins and selectins mediate chemotactic factor and endotoxin-enhanced neutrophil sequestration in the lung. Am J Pathol 2001;158: 18091819.
  • 75
    Ramamoorthy C, Sasaki SS, Su DL, et al. CD18 adhesion blockade decreases bacterial clearance and neutrophil recruitment after intrapulmonary E coli, but not after S aureus. J Leukoc Biol 1997;61: 167172.
  • 76
    Mizgerd JP, Horwitz BH, Quillen HC, et al. Effects of CD18 deficiency on the emigration of murine neutrophils during pneumonia. J Immunol 1999;163:995999.
  • 77
    Kumasaka T, Doyle NA, Quinlan M, et al. Role of CD11/CD18 in neutrophil emigration during acute and recurrent Pseudomonas aeruginosa-induced pneumonia in rabbits. Am J Pathol 1996;148: 12971305.
  • 78
    Shattil SJ. Function and regulation of the β3 integrins in hemostasis and vascular biology. Thromb Haemost 1995;74:149155.
  • 79
    Wang R, Ambruso DR, Newman PJ. Truncation in the cytoplasmic domain of integrin α4β1 subunit confers an inactivated state for the αIIbβ3 complex in a variant type of Glanzmann thrombasthenia. Blood 1994;84:244a.
  • 80
    Boudreaux MK, Kvam K, Dillon AR, et al. Type I Glanzmann's thrombasthenia in a Great Pyrenees dog. Vet Pathol 1996;33:503511.
  • 81
    Patterson WR, Estry DW, Schwartz KA, et al. Absent platelet aggregation with normal fibrinogen binding in Basset Hound hereditary thrombopathy. Thromb Haemost 1989;24:10111015.
  • 82
    Byzova TV, Rabbani R, D'Souza SE, Plow EF. Role of integrin αvβ3 in vascular biology. Thromb Haemost 1998;80:726734.
  • 83
    van der Zee R, Murohara T, Passed J, et al. Reduced intimal thickening following alpha(v)beta3 blockade is associated with smooth muscle cell apoptosis. Cell Adhes Commun 1998;6:371379.
  • 84
    Kang IC, Lee YD, Kim DS. A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res 1999;59:37543760.
  • 85
    Kerr JS, Wexler RS, Mousa SA, et al. Novel small molecule αv integrin antagonists: Comparative anti-cancer efficacy with known angiogenesis inhibitors. Anticancer Res 1999;19(2A):959968.
  • 86
    Kajiji S, Tamura RN, Quaranta V. A novel integrin (αEβ4) from human epithelial cells suggests a fourth family of integrin adhesion receptors. EMBO J 1989;8:673680.
  • 87
    Kennel SJ, Godfrey V, Ch'ang LY, et al. The beta 4 subunit of the integrin family is displayed on a restricted subset of endothelium in mice. J Cell Sci 1992;101(Pt l):145150.
  • 88
    Niessen CM, Cremona O, Daams H, et al. Expression of the integrin α6β4 in peripheral nerves: Localization in Schwann and perineural cells and different variants of the beta 4 subunit. J Cell Sci 1994;107(Pt 2):543552.
  • 89
    Lee EC, Lotz MM, Steele GD Jr, Mercurio AM. The integrin alpha 6 beta 4 is a laminin receptor. J Cell Biol 1992;117:671678.
  • 90
    Falk-Marzillier J, Domanico SZ, Pelletier A, et al. Characterization of a tight molecular complex between integrin α6β4 and laminin-5 extracellular matrix. Biochem Biophys Res Commun 1998;251: 4955.
  • 91
    Gambaletta D, Marchetti A, Benedetti L, et al. Cooperative signaling between α6β4 integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem 2000;275:1060410610.
  • 92
    Hu MC-T, Crowe DT, Weissman IL, Holzmann B. Cloning and expression of mouse integrin βp(β7): A functional role in Peyer's patch-specific lymphocyte homing. Proc Natl Acad Sci USA 1992;89: 82548258.
  • 93
    Schweighoffer T, Tanaka Y, Tidswell M, et al. Selective expression of integrin α4β7 on a subset of human CD4+ memory T cells with hallmarks of gut-tropism. J Immunol 1993; 151:717729.
  • 94
    Brezinschek RI, Brezinschek H-P, Lazarovits Al, et al. Expression of the β7 integrin by human endothelial cells. Am J Pathol 1996; 149:16511660.
  • 95
    Berlin C, Berg EL, Briskin MJ, et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993;74:185195.
  • 96
    Cepek KL, Shaw SK, Parker CM, et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 1994;372:190193.
  • 97
    Lo SK, Everitt J, Gu J, Malik AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest 1992;89:981988.
  • 98
    Staunton DE, Marlin SD, Stratowa C, et al. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925933.
  • 99
    Constantin G, Piccio L, Bussini S, et al. Induction of adhesion molecules on human Schwann cells by proinflammatory cytokines, an immunofluorescence study. J Neurol Sci 1999;170:124130.
  • 100
    Radi ZA, Register K, Lee E-K, et al. In situ expression of intercellular adhesion molecule-1 (ICAM-1) in calves with acute Pasteurella haemolytica pneumonia. Vet Pathol 1999;36:437444.
  • 101
    Lee E, Kang SG, Kehrli ME jr. Cloning, sequencing and analysis of cDNA encoding bovine intercellular adhesion molecule-1 (ICAM-1). Vet Immunol Immunopathol 1997;59:121129.
  • 102
    Staunton DE, Dustin ML, Erickson HP, Springer TA. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 1990;61:243254.
  • 103
    Manning AM, Lu HF, Kukielka GL, et al. Cloning and comparative sequence analysis of the gene encoding canine intercellular adhesion molecule-1 (ICAM-1). Gene 1995;156:291295.
  • 104
    Sligh JE Jr, Ballatyne CM, Rich SS, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1993;90:85298533.
  • 105
    Ohno N, Ichikawa H, Coe L, et al. Soluble selectins and ICAM-1 modulate neutrophil endothelial adhesion and diapedesis in vitro. Inflammation 1997;21:313324.
  • 106
    Krenn V, Schedel J, Doring A, et al. Endothelial cells are the major source of sCAM-1 in rheumatoid synovial tissue. Rheumatol Int 1997; 17:1727.
  • 107
    Shingu M, Hashimoto M, Nobunaga M, et al. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis patients. Inflammation 1994; 18:2334.
  • 108
    Ridker PM, Hennekens CH, Roitman-Johnson B, et al. Plasma concentrations of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:8892.
  • 109
    Huguenel ED, Cohn D, Dockum DP, et al. Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am J Respir Crit Care Med 1997;155:12061210.
  • 110
    Turner RB, Wecker MT, Pohl G, et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: A randomized clinical trial. J Am Med Assoc 1999;281: 17971804.
  • 111
    de Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of the ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991;174:253267.
  • 112
    de Fougerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte functionassociated molecule 1 on resting lymphocytes. J Exp Med 1992;175: 185190.
  • 113
    Bailly P, Tontti E, Hermand P, et al. The red cell LW blood group protein is an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol 1995;25:33163320.
  • 114
    Tian L, Yoshihara Y, Mizuno T, et al. The neuronal glycoprotein telencephalin is a cellular ligand for the CD11a/CD18 leukocyte integrin. J Immunol 1997;158:928936.
  • 115
    Bloy C, Hermand P, Blanchard D, et al. Surface orientation and antigen properties of Rh and LW polypeptides of the human erythrocyte membrane. J Biol Chem 1990;265:2148221487.
  • 116
    Arii N, Mizuguchi M, Mori K, Takashima S. Development of telencephalin in the human cerebrum. Microsc Res Tech 1999;46:1823.
  • 117
    Benson DL, Yoshihara Y, Mori K. Polarized distribution and cell type-specific localization of telencephalin, an intercellular adhesion molecule. J Neurosci Res 1998;52:4353.
  • 118
    Kilgannon P, Turner T, Meyer J, et al. Mapping of the ICAM-5 (telencephalin) gene, a neuronal member of the ICAM family, to a location between ICAM-1 and ICAM-3 on human chromosome 19p13.2. Genomics 1998;54:328330.
  • 119
    Tamada A, Yoshihara Y, Mori K. Dendrite-associated cell adhesion molecule, telencephalin, promotes neurite outgrowth in mouse embryo. Neurosci Lett 1998;240:163166.
  • 120
    Yoshihara Y, Oka S, Nemoto Y, et al. An ICAM-related neuronal glycoprotein, telencephalin, with brain segment-specific expression. Neuron 1994; 12:541553.
  • 121
    Hino H, Mori K, Yoshihara Y, et al. Reduction of telencephalin immunoreactivity in the brain of patients with Alzheimer's disease. Brain Res 1997;753:353357.
  • 122
    Mizuno T, Yoshihara Y, Inazawa J, et al. cDNA cloning and chromosomal localization of the human telencephalin and its distinctive interaction with lymphocyte function-associated antigen-1. J Biol Chem 1997;272:11561163.
  • 123
    Iiino II, Mori K, Yoshihara Y, et al. Reduction of telencephalin immunoreactivity in the brain of patients with Alzheimer's disease. Brain Res 1997;753:353357.
  • 124
    Rieckmann P, Turner T, Kligannon P, Steinhoff BJ. Telencephalin as an indicator for temporal-lobe dysfunction. Lancet 1998;352: 370371.
  • 125
    Hession C, Tizard R, Vassallo C, et al. Cloning of an alternate form of vascular adhesion molecule-1 (VCAM1). J Biol Chem 1991; 266:66826685.
  • 126
    Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from VLA-4/fibronectin binding site. Cell 1990;60:577584.
  • 127
    Fries JW, Williams AJ, Atkins RC, et al. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 1993; 143:725737.
  • 128
    Weyrich AS, Buerke M, Albertine KH, Lefer AM. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol 1995;57:4555.
  • 129
    Shimizu Y, Mobley JL. Distinct cation requirements for integrin -mediated CD4+ T lymphocyte adhesion to ICAM-1, fibronectin, VCAM-1, and invasion. J Immunol 1993;151:41064115.
  • 130
    Koch AE, Halloran MM, Haskell CJ, et al. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376:517519.
  • 131
    Tokuhira M, Hosaka S, Volin MV, et al. Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum 2000; 43:11221133.
  • 132
    Kitani A, Nakashima N, Izumihara T, et al. Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. J Immunol 1998;161:49314938.
  • 133
    Gurbel PA, Serebruany VL. Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents. Am J Cardiol 1998;81:772775.
  • 134
    Jager A, van Hinsberg VW, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: The Hoorn study. Diabetes 2000;49:485491.
  • 135
    Kaplanski G, Cacoub P, Faarnarier C, et al. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: Correlations with the severity of thrombosis. Arthritis Rheum 2000;43:5564.
  • 136
    Adams DH, Shaw S. Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 1994;343:831836.
  • 137
    Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): Inhibition of TCR-mediated signal transduction. J Immunol 1999;163:682688.
  • 138
    Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration: Studies in vitro and in vivo. J Leukoc Biol 1995;57:523528.
  • 139
    Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:12191222.
  • 140
    Xie Y, Muller WA. Molecular cloning and adhesive properties of murine platelet/endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA 1993;90:55695573.
  • 141
    Muller WA, Weigel SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178:449460.
  • 142
    Gurubhagavatula I, Amrani Y, Pratico D, et al. Engagement of human PECAM-1 (CD31) on human endothelial cells increases intracellular calcium ion concentration and stimulates prostacyclin release. J Clin Invest 1998;101:212222.
  • 143
    Jackson DE, Loo RO, Holyst MT, Newman PJ. Identification and characterization of functional cation coordination sites in platelet endothelial cell adhesion molecule-1. Biochemistry 1997;36:93959404.
  • 144
    Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): A novel vascular cell-cell adhesion molecule. J Cell Biol 1991;114:10591068.
  • 145
    Kukielka GL, Hawkins HK, Michael L, et al. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemia and reperfused canine myocardium. J Clin Invest 1993;92:15041516.
  • 146
    Welbourn CR, Goldman G, Paterson IS, et al. Pathophysiology of ischemia reperfusion injury: Central role of the neutrophil. Br J Surg 1991;78:651655.
  • 147
    Rubin P, Dube L, Braeckman R, et al. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipooxygenase. Agents Actions Suppl 1991;35:103116.
  • 148
    Blanco FJ, Guitian R, Moreno J, et al. Effect of anti-inflammatory drugs on COX-1 and COX-2 activity in human articular chon-drocytes. J Rheumatol 1999;26:13661373.
  • 149
    Depre M, Van Hecken A, Verbesselt R, et al. Pharmacokinetic and pharmacodynamic interaction between the lipooxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man. Int J Pharmacol Res 1998;18:5361.
  • 150
    Mihelcic D, Schleiffenbaum B, Tedder TF, et al. Inhibition of leukocyte L-selectin function with a monoclonal antibody attenuates reperfusion injury to the rabbit ear. Blood 1994;84:23222328.
  • 151
    Pierce JW, Read MA, Ding H, et al. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 1996;156:39613969.
  • 152
    Cheng Z, Nolan AM, Mckellar QA. Measurement of cyclooxygenase inhibition in vivo: A study of two non-steroidal anti-inflammatory drugs in sheep. Inflammation 1998;22:353366.
  • 153
    Garcia-Vicuna R, Diaz-Gonzalez F, Gonzalez-Alvaro I, et al. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family. Arthritis Rheum 1997;40:143153.
  • 154
    Burton JL, Kehrli ME Jr, Kapil S, Horst RL. Regulation of L-selectin and CD 18 on bovine neutrophils by glucocorticoids: Effects of cortisol and dexamethasone. J Leukoc Biol 1995;57:317325.
  • 155
    Filep JG, Delalandre A, Payette Y, Foldes-Filep E. Glucocor-ticoid receptor regulates expression of L-selectin and CD 1 I/CD 18 on human neutrophils. Circulation 1997;96:295301.
  • 156
    Burton JL, Kehrli ME jr. Effects of dexamethasone on bovine circulating T lymphocyte populations. J Leukoc Biol 1996;59:9099.
  • 157
    Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cach-ectin/tumor necrosis factor reduce interleukin 1 beta and interleucin 6 appearance during lethal bacteremia. J Exp Med 1989; 170:16271633.
  • 158
    Lorenz HM, Antoni C, Valerius T, et al. In vivo blockade of TNF-α by intravenous infusion of a chimeric monoclonal TNF-α antibody in patients with rheumatoid arthritis. Short term cellular and molecular effects. J Immunol 1996;156:16461653.
  • 159
    Lorenz HM, Grunke M, Hieronymus T, et al. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: Longterm effects after repeated infusion of chimeric monoclonal antibody cA2. J Rheumatol 2000;27:304310.
  • 160
    Starnes HF Jr, Pearce MK, Tewari A, et al. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice. J Immunol 1990; 145:41854191.
  • 161
    Hammelmann E, Cieslewicz G, Schwarze J, et al. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am J Respir Crit Care Med 1999;160:934941.
  • 162
    Shardonofsky FR, Venzor J III, Barrios R, et al. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J Allergy Clin Immunol 1999;104:215221.
  • 163
    Ormrod DJ, Miller TE. The anti-inflammatory activity of a low molecular weight component derived from the milk of hyperim-munized cows. Agents Actions 1991;32:160166.
  • 164
    Badovinac V, Mostarica-Stojkovic M, Dinarello CA, Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J Neuroimmunol 1998;85:8795.
  • 165
    Haak-Frendscho M, Marsters SA, Mordenti J, et al. Inhibition of TNF by a TNF receptor immunoadhesion. Comparison to an anti-TNF monoclonal antibody. J Immunol 1994; 152: 134713 53.
  • 166
    Kondo S, Pastore S, Fujisawa H, et al. Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J Invest Dermatol 1995; 105:334338.
  • 167
    Pan RY, Chen SL, Xiao X, et al. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum 2000; 43:289297.
  • 168
    Ashkenazi A, Marsters SA, Capon DJ, et al. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesion. Proc Natl Acad Sci USA 1991;88:1053510539.
  • 169
    Mohler KM, Torrance DS, Smith CA, et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 1993;151:15481561.
  • 170
    Henderson WR Jr, Chi EY, Maliszewski CR. Soluable IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J Immunol 2000;164:10861095.
  • 171
    Rubin LA, Nelson DL. The soluble interleukin-2 receptor: Biology, function, and clinical application. Ann Intern Med 1990;113: 619627.
  • 172
    Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547550.
  • 173
    Horsfall AC, Butler DM, Marinova L, et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. J Immunol 1997; 159:56875696.
  • 174
    Mulligan MS, Jones ML, Vaporciyan AA, et al. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J Immunol 1993;151:56665674.
  • 175
    Frevert CW, Matute-Bello G, Skerrett SJ, et al. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. J Immunol 2000;164:54395445.
  • 176
    Haziot A, Rong GW, Lin XY, et al. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J Immunol 1995;154:65296532.
  • 177
    Krakauer T. Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. Immunopharmacology 2000;46:253261.
  • 178
    Lo CJ, Fu M, Lo FR, Cryer HG. Cyclooxygenase 2 (COX-2) gene activation is regulated by cyclic adenosine monophosphate. Shock 2000;13:4145.
  • 179
    Neuner P, Klosner G, Schauer E, et al. Pentoxifylline in vivo down-regulates the release of IL-1 beta, IL-6, IL-8 and TNF-α by human peripheral blood mononuclear cells. Immunology 1994;83: 262267.
  • 180
    Olmos JM, De Vega T, Perera L, et al. Etidronate inhibits the production of IL-6 by osteoblast-like cells. Methods Find Exp Clin Pharmacol 1999;21:519522.
  • 181
    Parmely MJ, Zhou WW, Edwards CK III, et al. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J Immunol 1993;151:389396.
  • 182
    Shimizu N, Watanabe T, Arakawa T, et al. Pentoxifylline accelerates gastric ulcer healing in rats: Roles of tumor necrosis factor alpha and neutrophils during the early phase of ulcer healing. Digestion 2000;61:157164.
  • 183
    Tibes U, Rohr SP, Scheuer W, et al. Suppression of acute experimental inflammation by antisense oligonucleotides targeting secretory phospholipase A2 (sPLA2) in vitro and in vivo experiments. Adv Exp Med Biol 1999;469:199207.
  • 184
    Noonan TC, Gundel RH, Desai SN, et al. The effects of an anti-CD18 antibody (R15.7) in antigen-induced airway hyperrespon-siveness (AH) and cell influx in guinea pigs. Agents Actions 1991;34: 211213.
  • 185
    Elliott E, Li Z, Bell C, et al. Modulation of host response to Escherichia coli O157:H7 infection by anti-CD18 antibody in rabbits. Gastroenterology 1994;106:15541561.
  • 186
    Kling D, Fingerle J, Harlan JM, et al. Mononuclear leukocytes invade rabbit arterial intima during thickening formation via CD18-and VLA-4-dependent mechanisms and stimulate smooth muscle migration. Circ Res 1995;77:11211128.
  • 187
    Yednock TA, Cannon C, Fritz LC, et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 1992;356:6366.
  • 188
    Molossi S, Elices M, Arrhenius T, et al. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J Clin Invest 1995;95:26012610.
  • 189
    Wahl SM, Allen JB, Hines KL, et al. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J Clin Invest 1994;94:655662.
  • 190
    Yanaka K, Camarata PJ, Spellman SR, et al. Neuronal protection from cerebral ischemia by synthetic fibronectin peptides to leukocyte adhesion molecules. J Cereb Blood Flow Metab 1996; 16:11201125.
  • 191
    Bator JM, Weitzberg M, Burch RM. N-[9H-(2,7-dimethymuorenyl-9 methoxy)carbonyl]-L-leucine, NPC 15669, prevents neutrophil adherence to endothelium and inhibits CDllb/CD18 upregulation. Immunopharmacology 1992;23:139149.
  • 192
    Burch RM, Weitzberg M, Blok N, et al. N-(fluorenyl-9-meth-oxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action. Proc Natl Acad Sci USA 1991;88:355359.
  • 193
    Norohana-Blob L, Lowe VC, Muhlhauser RO, Burch RM. NPC 15669, an inhibitor of neutrophil recruitment, is efficacious in acetic acid-induced colitis in rats. Gastroenterology 1993; 104:10211029.
  • 194
    Pou S, Gunther MR, Pou WS, et al. Effect of NPC 15669, an inhibitor of neutrophil recruitment and neutrophil-mediated inflammation, on neutrophil function in vitro. Biochem Pharmacol 1993;45: 21232127.
  • 195
    Miller MJ, Chotinaruemol S, Sadowska-Krowikca H, et al. Guinea pig ileitis is attenuated by the leumidin N-(fluorenyl-9-meth-oxycarbonyl)-leucine (NPC 15199). J Pharmacol Exp Ther 1993; 266: 468472.
  • 196
    Lowe VC, Noronha-Blob L. The leukocyte recruitment inhibitor, NPC 15669, accelerates healing in acetic acid-induced colitis. Agents Actions 1993;39:C80C82.
  • 197
    Altavilla D, Squadrito F, Ioculano M, et al. E-selectin in the pathogenesis of experimental myocardial ischemia-reperfusion injury. Eur J Pharmacol 1994;270:4551.
  • 198
    Moore TM, Khimenko P, Adkins WK, et al. Adhesion molecules contribute to ischemia and reperfusion-induced injury in the isolated rat lung. J Appl Physiol 1995;78:22452252.
  • 199
    Winn RK, Paulson JC, Harlan JM. A monoclonal antibody to P-selectin ameliorates injury associated with hemorrhagic shock in rabbits. Am J Physiol 1994;267:H2391H2397.
  • 200
    Condon TP, Bennett CE. Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells. J Biol Chem 1996;271:3039830403.
  • 201
    Lo SK, Bevilacqua B, Malik AB. E-selectin ligands mediate tumor necrosis factor-induced neutrophil sequestration and pulmonary edema in guinea pig lungs. Circ Res 1994;75:955960.
  • 202
    Hayashi H, Koike H, Kurata Y, et al. Protective effects of sialyl Lewis X and anti-P-selectin antibody against lipopolysaccharide-induced acute lung injury in rabbits. Eur J Pharmacol 1999;370:4756.
  • 203
    Zimmerman BJ, Paulson JC, Arrhenius TS, et al. Thrombin receptor peptide-mediated leukocyte rolling in rat mesenteric venules: Roles of P-selectin and sialyl Lewis X. Am J Physiol 1994; 267: H1049H1053.
  • 204
    Ridings PC, Holloway S, Bloomfield GL, et al. Protective role of synthetic sialylated oligosaccharide in sepsis-induced acute lung injury. J Appl Physiol 1997;82:644651.
  • 205
    Huang J, Kim LJ, Mealey R, et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999;285:595599.
  • 206
    Kogan TP, Dupre B, Bui H, et al. Novel synthetic inhibitors of selectin-mediated cell adhesion: Synthesis of l,6-Bis[3-(3-carbox-ymethylphenyl)-4-(2-α-D-mannopyranosyloxy)phenyl]hexane (TBC1269). J Med Chem 1998;41:10991111.
  • 207
    Radi Z, Caverly J, Dixon R, et al. Effects of a synthetic selectin inhibitor, TBC1269, on tissue damage in acute Mannheimia (Pasteurella) haemolytica pneumonia in neonatal calves. Am J Vet Res 2001; 62(1):1722.
  • 208
    Caverly JM, Radi ZA, Andreasen CB, et al. Comparison of bronchoalveolar lavage fluid between P. haemolytica-inoculated calves and calves pre-treated with the selectin inhibitor, TBC1269. Am J Vet Res 2001;62:665672.
  • 209
    Abraham WM, Ahmed A, Sabater JR, et al. Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med 1999; 159 (4 Pt 1): 12051214.
  • 210
    Abraham WM, Gill A, Ahmed A, et al. A small-molecule, tight-binding inhibitor of the integrin alpha(4)beta(l) blocks antigen-induced airway responses and inflammation in experimental asthma in sheep. Am J Respir Crit Care Med 2000;162(2 Pt l):603611.
  • 211
    Scuri M, Allegra L, Abraham WM. The effects of multiple dosing with zileuton on antigen-induced responses in sheep. Pulm Pharmacol Ther 1998;11 (4):277280.
  • 212
    Abraham WM, Ahmed A, Sielczak MW, et al. Blockade of late-phase airway responses and airway hyperresponsiveness in allergic sheep with a small-molecule peptide inhibitor of VLA-4. Am J Respir Crit Care Med 1997; 156(3 Pt l):696703.
  • 213
    Harning R, Pelletier J, Van G, et al. Monoclonal antibody to MALA-2 (ICAM-1) reduces acute autoimmune nephritis in kdkd mice. Clin Immunol Immunopathol 1992;64:129134.
  • 214
    Wong P, Yue G, Yin K, et al. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease. J Pharmacol Exp Ther 1995;274:475480.
  • 215
    Cosimi AB, Conti D, Delmonico FL, et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol 1990; 144:46044612.
  • 216
    Aziz KE, Wakefield D. Modulation of endothelial cell expression of ICAM-1, E selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Cell Immunol 1996; 167:7985.
  • 217
    Jilma B, Blann AD, Stohlawetz P, et al. Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men. J Lab Clin Med 2000;135:270274.
  • 218
    Juan M, Mullol J, Roca-Ferrer J, et al. Regulation of ICAM-3 and other adhesion molecule expressions on eosinophils in vitro. Effects of dexamethasone. Allergy 1999;54:12931298.
  • 219
    Papi A, Papadopoulos NG, Degitz K, et al. Corticosteroids inhibit rhinovirus-induced intercellular adhesion molecule-1 up-regulation and promoter activation on respiratory epithelial cells. J Allergy Clin Immunol 2000;105:318326.
  • 220
    Bennett CF, Condon TP, Grimm S, et al. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J Immunol 1994;152:35303540.
  • 221
    Chen W, Bennett CF, Wang ME, et al. Perfusion of kidneys with unformulated “naked” intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury. Transplantation 1999;68:880887.
  • 222
    Cheng QL, Chen XM, Li F, et al. Effects of ICAM-1 antisense oligonucleotide on the tubulointerstitium in mice with unilateral ureteral obstruction. Kidney Int 2000; 57:183190.
  • 223
    Dragun D, Tullius SG, Park JK, et al. ICAM-1 antisense oligodeoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 1998;54:590602.
  • 224
    Haller H, Dragun D, Miethke A, et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 1996;50:473480.
  • 225
    Stepkowski SM, Tu Y, Condon TP, Bennett CF. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J Immunol 1994;153:53365346.
  • 226
    Klimuk SK, Semple SC, Nahirney PN, et al. Enhanced antiinflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity. J Pharmacol Exp Ther 2000;292:480488.